Valor Intrínseco del S&P y Nasdaq Contáctenos

Viridian Therapeutics, Inc. VRDN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$43.10
+189.7%

Viridian Therapeutics, Inc. (VRDN) has 20 tenedores institucionales e internos conocidos registrados. El mayor tenedor es Logos Global Master Fund LP con 6,000,000 acciones. Otros tenedores destacados incluyen Fairmount Funds Management LLC y Atlas Venture Fund VII L P.

En los últimos 12 meses, los internos han realizado 25 transacciones en VRDN acciones — 12 compras (valoradas en $11.82M) y 1 ventas (valoradas en $70.8K). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.

VRDN Participación de Insiders

Principal Titular
Logos Global Master Fund LP
6,000,000 acciones
Compras (12 meses)
12
$11.82M valor
Ventas (12 meses)
1
$70.8K valor
Actividad de Transacciones (12 meses)
Comprar 48%
Vender 4%
Principales Titulares Internos
# Nombre Cargo Acciones en Propiedad Última Declaración Tamaño Relativo
1 Logos Global Master Fund Lp 10 Percent Owner 6,000,000 2020-11-16
100%
2 Fairmount Funds Management Llc 10 Percent Owner 3,914,458 2025-10-27
65%
3 Atlas Venture Fund Vii L P 10 Percent Owner 3,142,580 2017-02-13
52%
4 Remeditex Ventures Llc 10 Percent Owner 2,706,563 2017-02-13
45%
5 Frazier Life Sciences Public Fund, L.p. 10 Percent Owner 1,505,200 2021-09-28
25%
6 Fairmount Healthcare Fund Ii L.p. Director 1,363,764 2022-08-19
23%
7 Marshall William Stuart President & CEO 464,000 2020-02-14
8%
8 Point72 Asset Management, L.p. 10 Percent Owner 426,162 2020-11-20
7%
9 Ra Capital Management, L.p. 10 Percent Owner 410,686 2020-12-17
7%
10 Leverone Jason A. Chief Financial Officer 311,785 2021-01-20
5%
11 Escolar Diana Chief Medical Officer 270,000 2020-02-14
5%
12 Myers Scott Dunseth Chief Executive Officer 259,500 2023-04-12
4%
13 Violin Jonathan Chief Executive Officer 239,205 2023-02-07
4%
14 Riccitelli Samuel D President & CEO 200,000 2016-05-19
3%
15 Katz Barrett Chief Medical Officer 108,000 2023-02-10
2%
16 Humer Kristian CFO and Cbo 108,000 2023-02-10
2%
17 Rubin Paul D EVP, Research & Development 87,000 2019-02-08
1%
18 Levy Adam Scott Chief Business Officer 74,000 2019-02-08
1%
19 Melvin Carrie COO 54,000 2023-02-10
1%
20 Ciulla Thomas Chief Medical Officer 50,000 2024-02-07
1%
Transacciones Recientes (últimos 12 meses)
Fecha Nombre Cargo Tipo Acciones Precio Valor
2026-03-03 Tousignant Jennifer Chief Legal Officer Retención Fiscal de RSU 1,675 $30.19 $50.57K
2026-03-03 Harmon Seth Chief Financial Officer Retención Fiscal de RSU 2,031 $30.19 $61.32K
2026-03-03 Mahoney Stephen F. President and CEO Retención Fiscal de RSU 7,408 $30.19 $223.65K
2026-03-03 Beetham Thomas W. Chief Operating Officer Retención Fiscal de RSU 3,048 $30.19 $92.02K
2026-03-03 Tousignant Jennifer Chief Legal Officer Retención Fiscal de RSU 1,724 $29.32 $50.55K
2026-03-02 Tousignant Jennifer Chief Legal Officer Concesión de RSU 23,850 - -
2025-03-03 Tousignant Jennifer Officer Desconocido - - -
2026-03-03 Harmon Seth Chief Financial Officer Retención Fiscal de RSU 2,091 $29.32 $61.31K
2026-03-02 Harmon Seth Chief Financial Officer Concesión de RSU 20,550 - -
2025-03-03 Harmon Seth Officer Desconocido - - -
2026-03-02 Tripuraneni Radhika Chief Medical Officer Concesión de RSU 19,150 - -
2026-03-03 Mahoney Stephen F. President and CEO Retención Fiscal de RSU 7,627 $29.32 $223.62K
2026-03-02 Mahoney Stephen F. President and CEO Concesión de RSU 111,900 - -
2026-03-03 Beetham Thomas W. Chief Operating Officer Retención Fiscal de RSU 3,138 $29.32 $92.01K
2026-03-02 Beetham Thomas W. Chief Operating Officer Concesión de RSU 35,300 - -
2025-12-31 Tousignant Jennifer Chief Legal Officer Venta Informativa 2,272 $31.16 $70.8K
2025-10-23 Fairmount Funds Management Llc 10 Percent Owner Compra Informativa 454,545 $22.00 $10M
2025-07-01 Gheuens Sarah Director Concesión de RSU 21,000 $14.47 $303.87K
2025-07-01 Kiselak Tomas Director Concesión de RSU 21,000 $14.47 $303.87K
2025-07-01 Cain Christopher W. Director Concesión de RSU 21,000 $14.47 $303.87K
2025-07-01 Moses Jennifer K. Director Concesión de RSU 21,000 $14.47 $303.87K
2025-07-01 Ajer Jeffrey Robert Director Concesión de RSU 21,000 $14.47 $303.87K
2025-07-01 Morris Arlene Director Concesión de RSU 21,000 $14.47 $303.87K
2025-06-10 Fairmount Funds Management Llc 10 Percent Owner Ejercicio de Opciones (Venta) 12,500 $12.31 $153.88K
2025-06-09 Fairmount Funds Management Llc 10 Percent Owner Ejercicio de Opciones (Venta) 1,600 $7.80 $12.48K
Contáctenos
🎓
SharesGrow Academia
Aprende a calcular el Valor Intrínseco y encontrar acciones infravaloradas.
Sesiones semanales en vivo
Envíanos un mensaje